{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bibliometric analysis", "bone marrow adipocyte", "hematological malignancy", "hematopoiesis", "metabolic reprogramming"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37926488", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1111/ijlh.14198"], "Journal": {"ISSN": "1751-553X", "JournalIssue": {"Volume": "46", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Feb"}}, "Title": "International journal of laboratory hematology", "ISOAbbreviation": "Int J Lab Hematol"}, "ArticleTitle": "Bone marrow adipocyte: Origin, biology and relationship with hematological malignancy.", "Pagination": {"StartPage": "10", "EndPage": "19", "MedlinePgn": "10-19"}, "Abstract": {"AbstractText": ["Bone marrow adipose tissue (BMAT) has been histologically recognized for decades. In this study, we performed a bibliometric analysis to quantitatively analyze the clusters of keywords of BMAT and hematopoiesis to better understand BMAT and hematopoiesis. Starting with conclusive keywords, our results demonstrated that BMAds is distinct from extramedullary adipose tissues and maintains a routine but dynamic accumulation throughout an individual's life. Various pathophysiological factors take part in dysregulation of the adipose-osteogenic balance throughout life. Bone marrow adipocytes (BMAds) are also contradictorily involved in normal hematopoiesis, and positively participate in the occurrence and progression of hematologic malignancies, exerting a chemoprotective role in tumor treatment. Mechanically, metabolic reprogramming and abnormal secretory profile of BMAds and tumor cells play a critical role in the chemotherapy resistance. Overall, we hope that this work will provide new ideas for relevant future research on BMAds."], "CopyrightInformation": "\u00a9 2023 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0003-0572-0851"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Institute of Hematological Malignancies, Guiyang, China."}, {"Identifier": [], "Affiliation": "School for Clinical Laboratory, Guizhou Medical University, Guiyang, China."}], "LastName": "Wang", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pediatrics, Guizhou Medical University, Guiyang, China."}], "LastName": "Yang", "ForeName": "Chunxia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}], "LastName": "Wan", "ForeName": "Junzhao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Institute of Hematological Malignancies, Guiyang, China."}], "LastName": "Liu", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Clinical Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Yu", "ForeName": "Hantao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pediatrics, Guizhou Medical University, Guiyang, China."}], "LastName": "Yang", "ForeName": "Xiaoyan", "Initials": "X"}, {"Identifier": ["0000-0002-9220-7898"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Institute of Hematological Malignancies, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Ma", "ForeName": "Dan", "Initials": "D"}], "GrantList": [{"GrantID": "82160704", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "8206003", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "82003835", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "ZK[2022]General-451", "Agency": "Basic Research Program of Guizhou Province Technology Bureau", "Country": ""}, {"GrantID": "ZK [2021] General-399", "Agency": "Basic Research Program of Guizhou Province Technology Bureau", "Country": ""}, {"GrantID": "ZK[2022]General-412", "Agency": "Basic Research Program of Guizhou Province Technology Bureau", "Country": ""}, {"GrantID": "ZK[2023]General-383", "Agency": "Basic Research Program of Guizhou Province Technology Bureau", "Country": ""}, {"GrantID": "gzwkj2021-158", "Agency": "Science and Technology Program of Guizhou Province Health Committee", "Country": ""}, {"GrantID": "gzwkj2021-466", "Agency": "Science and Technology Program of Guizhou Province Health Committee", "Country": ""}, {"GrantID": "gzwkj2021-468", "Agency": "Science and Technology Program of Guizhou Province Health Committee", "Country": ""}, {"GrantID": "22NSFCP56", "Agency": "Cultivation Program to National Natural Science Foundation of Affiliated Hospital of Guizhou Medical University", "Country": ""}, {"GrantID": "22NSFCP58", "Agency": "Cultivation Program to National Natural Science Foundation of Affiliated Hospital of Guizhou Medical University", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Int J Lab Hematol", "NlmUniqueID": "101300213", "ISSNLinking": "1751-5521"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Bone Marrow"}, {"QualifierName": ["metabolism"], "DescriptorName": "Adipocytes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Adipose Tissue"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hematologic Neoplasms"}, {"QualifierName": [], "DescriptorName": "Biology"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wei N, Xu Y, Li Y, et al. A bibliometric analysis of T cell and atherosclerosis. Front Immunol. 2022;13:948314. doi:10.3389/fimmu.2022.948314"}, {"Citation": "de Paula FJA, Rosen CJ. Marrow adipocytes: origin, structure, and function. Annu Rev Physiol. 2020;82:461-484. doi:10.1146/annurev-physiol-021119-034513"}, {"Citation": "Robino JJ, Pamir N, Rosario S, et al. Spatial and biochemical interactions between bone marrow adipose tissue and hematopoietic stem and progenitor cells in rhesus macaques. Bone. 2020;133:115248. doi:10.1016/j.bone.2020.115248"}, {"Citation": "Shafat MS, Oellerich T, Mohr S, et al. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood. 2017;129(10):1320-1332. doi:10.1182/blood-2016-08-734798"}, {"Citation": "Sebo ZL, Rendina-Ruedy E, Ables GP, et al. Bone marrow adiposity: basic and clinical implications. Endocr Rev. 2019;40(5):1187-1206. doi:10.1210/er.2018-00138"}, {"Citation": "Kahn DE, Bergman BC. Keeping it local in metabolic disease: adipose tissue paracrine signaling and insulin resistance. Diabetes. 2022;71(4):599-609. doi:10.2337/dbi21-0020"}, {"Citation": "Audano M, Pedretti S, Caruso D, Crestani M, De Fabiani E, Mitro N. Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview. Cell Mol Life Sci: CMLS. 2022;79(3):139. doi:10.1007/s00018-022-04169-6"}, {"Citation": "Fairfield H, Condruti R, Farrell M, et al. Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells. Front Oncol. 2022;12:912834. doi:10.3389/fonc.2022.912834"}, {"Citation": "Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84(1):277-359. doi:10.1152/physrev.00015.2003"}, {"Citation": "Sanchez-Gurmaches J, Guertin DA. Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed. Nat Commun. 2014;5:4099. doi:10.1038/ncomms5099"}, {"Citation": "Subramani M, Yun JW. Loss of lymphocyte cytosolic protein 1 (LCP1) induces browning in 3T3-L1 adipocytes via \u03b23-AR and the ERK-independent signaling pathway. Int J Biochem Cell Biol. 2021;138:106053. doi:10.1016/j.biocel.2021.106053"}, {"Citation": "Long JZ, Svensson KJ, Tsai L, et al. A smooth muscle-like origin for beige adipocytes. Cell Metab. 2014;19(5):810-820. doi:10.1016/j.cmet.2014.03.025"}, {"Citation": "Bredella MA, Buckless C, Fazeli PK, et al. Bone marrow adipose tissue composition following high-caloric feeding and fasting. Bone. 2021;152:116093. doi:10.1016/j.bone.2021.116093"}, {"Citation": "Horowitz MC, Berry R, Holtrup B, et al. Bone marrow adipocytes. Adipocyte. 2017;6(3):193-204. doi:10.1080/21623945.2017.1367881"}, {"Citation": "Hardouin P, Rharass T, Lucas S. Bone marrow adipose tissue: to be or not to be a typical adipose tissue? Front Endocrinol. 2016;7:85. doi:10.3389/fendo.2016.00085"}, {"Citation": "Zhong L, Yao L, Tower RJ, et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. eLife. 2020;9:e54695. doi:10.7554/eLife.54695"}, {"Citation": "Baccin C, Al-Sabah J, Velten L, et al. Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization. Nat Cell Biol. 2020;22(1):38-48. doi:10.1038/s41556-019-0439-6"}, {"Citation": "Greenbaum A, Hsu YM, Day RB, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 2013;495(7440):227-230. doi:10.1038/nature11926"}, {"Citation": "Chen Q, Shou P, Zheng C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7):1128-1139. doi:10.1038/cdd.2015.168"}, {"Citation": "Zhang L, Fu X, Ni L, et al. Hedgehog signaling controls bone homeostasis by regulating osteogenic/adipogenic fate of skeletal stem/progenitor cells in mice. J Bone Miner Res. 2022;37(3):559-576. doi:10.1002/jbmr.4485"}, {"Citation": "Jing H, Liao L, An Y, et al. Suppression of EZH2 prevents the shift of osteoporotic MSC fate to adipocyte and enhances bone formation during osteoporosis. Mol Ther: J Am Soc Gene Ther. 2016;24(2):217-229. doi:10.1038/mt.2015.152"}, {"Citation": "Deng P, Yuan Q, Cheng Y, et al. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell. 2021;28(6):1057-1073.e7. doi:10.1016/j.stem.2021.01.010"}, {"Citation": "Ye L, Fan Z, Yu B, et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell. 2012;11(1):50-61. doi:10.1016/j.stem.2012.04.009"}, {"Citation": "Shen GS, Zhou HB, Zhang H, et al. The GDF11-FTO-PPAR\u03b3 axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(12):3644-3654. doi:10.1016/j.bbadis.2018.09.015"}, {"Citation": "Woods K, Guezguez B. Dynamic changes of the bone marrow niche: mesenchymal stromal cells and their progeny during aging and leukemia. Front Cell Dev Biol. 2021;9:714716. doi:10.3389/fcell.2021.714716"}, {"Citation": "Cuminetti V, Arranz L. Bone marrow adipocytes: the enigmatic components of the hematopoietic stem cell niche. J Clin Med. 2019;8(5):707. doi:10.3390/jcm8050707"}, {"Citation": "Scheller EL, Khandaker S, Learman BS, et al. Bone marrow adipocytes resist lipolysis and remodeling in response to \u03b2-adrenergic stimulation. Bone. 2019;118:32-41. doi:10.1016/j.bone.2018.01.016"}, {"Citation": "Li Y, Lu L, Xie Y, et al. Interleukin-6 knockout inhibits senescence of bone mesenchymal stem cells in high-fat diet-induced bone loss. Front Endocrinol. 2020;11:622950. doi:10.3389/fendo.2020.622950"}, {"Citation": "McGrath C, Sankaran JS, Misaghian-Xanthos N, et al. Exercise degrades bone in caloric restriction, despite suppression of marrow adipose tissue (BMAT). J Bone Miner Res. 2020;35(1):106-115. doi:10.1002/jbmr.3872"}, {"Citation": "Bitirim CV, Ozer ZB, Akcali KC. Estrogen receptor alpha regulates the expression of adipogenic genes genetically and epigenetically in rat bone marrow-derived mesenchymal stem cells. PeerJ. 2021;9:e12071. doi:10.7717/peerj.12071"}, {"Citation": "Liu P, Ji Y, Yuen T, et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017;546(7656):107-112. doi:10.1038/nature22342"}, {"Citation": "Yang M, Arai A, Udagawa N, et al. Parathyroid hormone shifts cell fate of a leptin receptor-marked stromal population from Adipogenic to osteoblastic lineage. J Bone Miner Res. 2019;34(10):1952-1963. doi:10.1002/jbmr.3811"}, {"Citation": "Suchacki KJ, Tavares AAS, Mattiucci D, et al. Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis. Nat Commun. 2020;11(1):3097. doi:10.1038/s41467-020-16878-2"}, {"Citation": "Tencerova M, Okla M, Kassem M. Insulin signaling in bone marrow adipocytes. Curr Osteoporos Rep. 2019;17(6):446-454. doi:10.1007/s11914-019-00552-8"}, {"Citation": "Reagan MR. Critical assessment of in vitro and in vivo models to study marrow adipose tissue. Curr Osteoporos Rep. 2020;18(2):85-94. doi:10.1007/s11914-020-00569-4"}, {"Citation": "Ambrosi TH, Scialdone A, Graja A, et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell. 2017;20(6):771-784.e6. doi:10.1016/j.stem.2017.02.009"}, {"Citation": "Polineni S, Resulaj M, Faje AT, et al. Red and white blood cell counts are associated with bone marrow adipose tissue, bone mineral density, and bone microarchitecture in premenopausal women. J Bone Miner Res. 2020;35(6):1031-1039. doi:10.1002/jbmr.3986"}, {"Citation": "Zhou BO, Yu H, Yue R, et al. Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF. Nat Cell Biol. 2017;19(8):891-903. doi:10.1038/ncb3570"}, {"Citation": "Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96(5):1723-1732. doi:10.1182/blood.V96.5.1723"}, {"Citation": "DiMascio L, Voermans C, Uqoezwa M, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol. 2007;178(6):3511-3520. doi:10.4049/jimmunol.178.6.3511"}, {"Citation": "Zinngrebe J, Debatin KM, Fischer-Posovszky P. Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders? Leukemia. 2020;34(9):2305-2316. doi:10.1038/s41375-020-0886-x"}, {"Citation": "Heydt Q, Xintaropoulou C, Clear A, et al. Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence. Nat Commun. 2021;12(1):5507. doi:10.1038/s41467-021-25540-4"}, {"Citation": "Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol. 2022;11(1):39. doi:10.1186/s40164-022-00292-z"}, {"Citation": "Han TJ, Wang X. Leptin and its receptor in hematologic malignancies. Int J Clin Exp Med. 2015;8(11):19840-19849."}, {"Citation": "Beaulieu A, Poncin G, Belaid-Choucair Z, et al. Leptin reverts pro-apoptotic and antiproliferative effects of \u03b1-linolenic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway. PLoS One. 2011;6(10):e25651. doi:10.1371/journal.pone.0025651"}, {"Citation": "Tan G, Shi L, Li Q, Wang M. Adiponectin enhances imatinib anti-tumour activity in human chronic myeloid leukaemia cells with serum levels associated with imatinib efficacy in early chronic phase patients. Cell Prolif. 2015;48(4):486-496. doi:10.1111/cpr.12194"}, {"Citation": "Morris EV, Suchacki KJ, Hocking J, et al. Myeloma cells Down-regulate adiponectin in bone marrow adipocytes via TNF-alpha. J Bone Miner Res. 2020;35(5):942-955. doi:10.1002/jbmr.3951"}, {"Citation": "Morris EV, Edwards CM. Adipokines, adiposity, and bone marrow adipocytes: dangerous accomplices in multiple myeloma. J Cell Physiol. 2018;233(12):9159-9166. doi:10.1002/jcp.26884"}, {"Citation": "Hsieh YT, Gang EJ, Geng H, et al. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood. 2013;121(10):1814-1818. doi:10.1182/blood-2012-01-406272"}, {"Citation": "Lu W, Wan Y, Li Z, et al. Growth differentiation factor 15 contributes to marrow adipocyte remodeling in response to the growth of leukemic cells. J Exp Clin Cancer Res: CR. 2018;37(1):66. doi:10.1186/s13046-018-0738-y"}, {"Citation": "Yang S, Lu W, Zhao C, et al. Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis. Haematologica. 2020;105(11):2572-2583. doi:10.3324/haematol.2019.225763"}, {"Citation": "Yao H, He S. Multi-faceted role of cancer-associated adipocytes in the tumor microenvironment (review). Mol Med Rep. 2021;24(6):866. doi:10.3892/mmr.2021.12506"}, {"Citation": "Liu H, He J, Koh SP, et al. Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci Transl Med. 2019;11(494):eaau9087. doi:10.1126/scitranslmed.aau9087"}, {"Citation": "Zhang L, Zhao Q, Cang H, et al. Acute myeloid leukemia cells educate mesenchymal stromal cells toward an Adipogenic differentiation propensity with leukemia promotion capabilities. Adv Sci (Weinh). 2022;9(16):2105811. doi:10.1002/advs.202105811"}, {"Citation": "Panaroni C, Fulzele K, Mori T, et al. Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins. Blood. 2022;139(6):876-888. doi:10.1182/blood.2021013832"}, {"Citation": "Tabe Y, Konopleva M, Andreeff M. Fatty acid metabolism, bone marrow adipocytes, and AML. Front Oncol. 2020;10:155. doi:10.3389/fonc.2020.00155"}, {"Citation": "Yan F, Shen N, Pang JX, et al. A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target. Leukemia. 2018;32(4):865-873. doi:10.1038/leu.2017.307"}, {"Citation": "Witkowski MT, Kousteni S, Aifantis I. Mapping and targeting of the leukemic microenvironment. J Exp Med. 2020;217(2):e20190589. doi:10.1084/jem.20190589"}, {"Citation": "Gonzalez MA, Olivas IM, Bencomo-Alvarez AE, et al. Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clin Transl Med. 2022;12(12):e1146. doi:10.1002/ctm2.1146"}, {"Citation": "Wu CY, Li GT, Chu CC, et al. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts. Arch Toxicol. 2023;97(2):377-392. doi:10.1007/s00204-022-03418-8"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "6", "Day": "12"}, {"Year": "2023", "Month": "10", "Day": "19"}, {"Year": "2024", "Month": "1", "Day": "19", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "6", "Hour": "0", "Minute": "41"}, {"Year": "2023", "Month": "11", "Day": "5", "Hour": "20", "Minute": "52"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37926488", "10.1111/ijlh.14198"]}}], "PubmedBookArticle": []}